Memorial Sloan Kettering (MSK) Cancer Center’s Senior Director of Clinical Research Informatics and Technology, Joe Lengfellner, tells us how MSK validated and scaled EHR-to-EDC technology across MSK’s vast portfolio of trials.
Editorial by Category
Clinical Trial Operations
View All
From the Archive: 6 Takeaways of DPHARM 2024 Keynote, Tufts’ Kenneth Getz, on Measuring DCT Return on Investment
DPHARM® Announces First Slate of Keynotes for 15th Annual Event
Leveraging AI to Streamline Clinical Development, with Formation Bio’s CDO
How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology
Immuno-Oncology and Cell Therapy
View All
T Cell Engagers, Moving Beyond Pembrolizumab, and Medicine Development for Future Patients, with Roche's Ashley Lakner
Pediatric Oncology’s Changing Regulatory Landscape and How to Navigate It
How Merck Research Labs Is Evolving its Global Clinical Supply to Meet the Demands of Newer Modalities
Leveraging a US-Chinese Biotech Collaboration to Develop a PD-1/VEGF Bispecific Antibody
Drug Delivery
View All
Patients as Partners in Clinical Research and Patient Access
View All
7 Key Takeaways of the Novo Nordisk Rare Disease Survey in Sickle Cell Disease from Patients as Partners 2025
The Role of the Chief Medical Officer In Championing Patient-Centric Drug Development
CRO Perspective on Connecting Advocacy and Industry to Advance Patient-Centric Medicine
How Patient Involvement Gets Done to Better Support Access, Decision-making and Medicine Development: Patients as Partners 2025 Recap
Biotech CMO/R&D Leadership
View All
CRAACO: Clinical Research as a Care Option
View All
How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology
Conference Forum Announces the Partnerships with Sites Summit to Improve Patient Enrollment
How CMOs can Champion Patient-Centric Drug Development
What Clinical Research Means to Patients in Ukraine, and How Industry Sponsors Can Help
Women Leadership in Biotech
View All
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
